Allogene Therapeutics (ALLO) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.51
-0.45
-0.38
-0.32

Details

Expected EPS
-0.332751
Actual EPS
-0.32
Surprise EPS
0.01
Surprise Percent
+3.83%

Description

⁨Allogene Therapeutics⁩ (⁦ALLO⁩) has reported earnings of ⁦-0.32⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts